|
Search
Collections
Benchmarks
Upload document
Organization
3D Medicines Co. Ltd.
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Postoperative prognosis in patients with NSCLC with different EGFR mutation sites.
Org:
3D Medicines Co. Ltd.,
